Latest Europe News

Nico Resources has completed preparations for a key infill drilling campaign at its Wingellina nickel-cobalt project, aiming to upgrade resource classifications and refine metallurgical understanding. The company also inked a strategic MOU with Pure Battery Technologies to explore regional refining opportunities amid a turbulent nickel price environment.

ADX Energy has secured A$3.58 million through a discounted placement to fund multi-zone testing at its HOCH-1 gas discovery in Austria, follow-up drilling, and offshore Sicily exploration amid Europe's tight gas market.

Elsight Limited (ASX:ELS) has shattered its revenue records in H1 2026, delivering a nearly fourfold increase over the prior year alongside expanding US defence contracts and new product launches.

Carnegie Clean Energy has secured $2.5 million through a share placement, attracting new overseas investors to fund expansion of its CETO wave energy technology at BiMEP in Spain and commercial activities in Europe and the US.

Macallum New Energy completed key 3D and 2D seismic surveys in Western Australia’s Perth Basin, setting the stage for prospect maturation and potential drilling in 2027 while maintaining a strong cash position.

Paladin Energy completes Langer Heinrich Mine ramp-up, delivering strong FY2026 results and advancing its Canadian PLS Project with a new uranium discovery. FY2027 guidance forecasts stable production and costs amid ongoing regulatory progress.

Ceretas Limited is raising $8 million through an IPO to fund clinical trials and development of its novel therapeutic ultrasound device targeting Alzheimer’s disease symptoms.

Lotus Resources confirms material operational setbacks at Kayelekera uranium project, including acid plant damage and production delays impacting offtake commitments. The company remains suspended pending critical funding arrangements.

Biotron has received pivotal regulatory feedback from the European Medicines Agency ruling out a Hybrid Marketing Authorisation for SedRx, prompting plans for pivotal clinical trials. The company also advances its lead antiviral candidate BIT-HBV001 against Hepatitis Delta Virus and appoints a new chairman.

Control Bionics has closed its Share Purchase Plan, raising $256,500 and pushing total capital raised to $9.75 million, pending shareholder approval for the final tranche.

Energy Transition Minerals (ASX:ETM) has completed its purchase of the Penouta Tin-Tantalum-Niobium mine in Spain, advancing its ambition to become a key European critical minerals producer with plans to restart operations.

Iondrive appoints ex-BHP innovation chief Dr Grant Caffery as CEO, signalling a pivot from development to commercial scale-up following strong rare earth recovery results and a US$15 million Oklahoma funding pathway.